Now Available!
The Expert’s Guide to Healthcare Product Due Diligence
Edited by Carl Osborne and Beth Silverstein, SciLucent, LLC

Due diligence is a critical step in business transactions involving healthcare products and the companies who manufacture and market them. Healthcare company professionals need to understand their company’s expectations regarding due diligence and how to optimize their role in the process.
The book is intended to provide individuals responsible for and participating in due diligence exercises with a framework and mindset for maximizing the value of the effort. The contributors to the book include professionals from the pharmaceutical, medical device, biotechnology, business development, and legal communities, each of whom has participated in conducting due diligence of healthcare products. Their collective goal is to provide guidance on how best to collect and maximize the value of the information collected and contribute effectively to the business transaction decision.
See FDLI at www.fdli.org/pubs or contact SciLucent for a copy.